417 related articles for article (PubMed ID: 23167424)
1. Characterization and resistance mechanisms of a 5-fluorouracil- resistant hepatocellular carcinoma cell line.
Gu W; Fang FF; Li B; Cheng BB; Ling CQ
Asian Pac J Cancer Prev; 2012; 13(9):4807-14. PubMed ID: 23167424
[TBL] [Abstract][Full Text] [Related]
2. Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells.
Gu W; Liu L; Fang FF; Huang F; Cheng BB; Li B
Oncol Rep; 2014 Jan; 31(1):216-22. PubMed ID: 24173654
[TBL] [Abstract][Full Text] [Related]
3. [Establishment of a multidrug-resistant cell line BEL-7402/5-FU of human hepatocellular carcinoma and its biological characteristics].
Gu W; Zhang YN; Li B; Han J; Cheng BB; Ling CQ
Zhong Xi Yi Jie He Xue Bao; 2006 May; 4(3):265-70. PubMed ID: 16696913
[TBL] [Abstract][Full Text] [Related]
4. MEL-pep, an analog of melittin, disrupts cell membranes and reverses 5-fluorouracil resistance in human hepatocellular carcinoma cells.
Ke M; Dong J; Wang Y; Zhang J; Zhang M; Wu Z; Lv Y; Wu R
Int J Biochem Cell Biol; 2018 Aug; 101():39-48. PubMed ID: 29800725
[TBL] [Abstract][Full Text] [Related]
5. The Effects and Mechanisms of Periplaneta americana Extract Reversal of Multi-Drug Resistance in BEL-7402/5-FU Cells.
Yuan F; Liu J; Qiao T; Li T; Shen Q; Peng F
Molecules; 2016 Jun; 21(7):. PubMed ID: 27367657
[TBL] [Abstract][Full Text] [Related]
6. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of 5-fluorouracil required resistance in human hepatocellular carcinoma cell line Bel(7402).
Jin J; Huang M; Wei HL; Liu GT
World J Gastroenterol; 2002 Dec; 8(6):1029-34. PubMed ID: 12439919
[TBL] [Abstract][Full Text] [Related]
8. TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells.
Lu F; Hou YQ; Song Y; Yuan ZJ
Anat Rec (Hoboken); 2013 Jan; 296(1):56-63. PubMed ID: 23125179
[TBL] [Abstract][Full Text] [Related]
9. Baicalein sensitizes hepatocellular carcinoma cells to 5-FU and Epirubicin by activating apoptosis and ameliorating P-glycoprotein activity.
Li J; Duan B; Guo Y; Zhou R; Sun J; Bie B; Yang S; Huang C; Yang J; Li Z
Biomed Pharmacother; 2018 Feb; 98():806-812. PubMed ID: 29571250
[TBL] [Abstract][Full Text] [Related]
10. Reversal effect of quercetin on multidrug resistance via FZD7/β-catenin pathway in hepatocellular carcinoma cells.
Chen Z; Huang C; Ma T; Jiang L; Tang L; Shi T; Zhang S; Zhang L; Zhu P; Li J; Shen A
Phytomedicine; 2018 Apr; 43():37-45. PubMed ID: 29747752
[TBL] [Abstract][Full Text] [Related]
11. MiR-183 modulates multi-drug resistance in hepatocellular cancer (HCC) cells via miR-183-IDH2/SOCS6-HIF-1α feedback loop.
Wang XJ; Zhang DL; Fu C; Wei BZ; Li GJ
Eur Rev Med Pharmacol Sci; 2016 May; 20(10):2020-7. PubMed ID: 27249600
[TBL] [Abstract][Full Text] [Related]
12. FUT family mediates the multidrug resistance of human hepatocellular carcinoma via the PI3K/Akt signaling pathway.
Cheng L; Luo S; Jin C; Ma H; Zhou H; Jia L
Cell Death Dis; 2013 Nov; 4(11):e923. PubMed ID: 24232099
[TBL] [Abstract][Full Text] [Related]
13. Astragaloside Ⅳ reduces the expression level of P-glycoprotein in multidrug-resistant human hepatic cancer cell lines.
Wang PP; Xu DJ; Huang C; Wang WP; Xu WK
Mol Med Rep; 2014 Jun; 9(6):2131-7. PubMed ID: 24676670
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound.
Hu Z; Lv G; Li Y; Li E; Li H; Zhou Q; Yang B; Cao W
J Exp Clin Cancer Res; 2016 Apr; 35():71. PubMed ID: 27102814
[TBL] [Abstract][Full Text] [Related]
15. Quantitative proteomic and phosphoproteomic studies reveal novel 5-fluorouracil resistant targets in hepatocellular carcinoma.
Liu Z; Wang Y; Yao Y; Fang Z; Miao QR; Ye M
J Proteomics; 2019 Sep; 208():103501. PubMed ID: 31454556
[TBL] [Abstract][Full Text] [Related]
16. Biological features, gene expression profile, and mechanisms of drug resistance of two- and three-dimensional hepatocellular carcinoma cell cultures.
Mei N; Zhao N; Tian T; Jiao M; Li C
Pharmacol Res Perspect; 2021 Feb; 9(1):e00715. PubMed ID: 33486902
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the multi-drug resistant human hepatocellular carcinoma cell line Bel-7402/ADM model established by three methods.
Zhong X; Xiong M; Meng X; Gong R
J Exp Clin Cancer Res; 2010 Aug; 29(1):115. PubMed ID: 20727186
[TBL] [Abstract][Full Text] [Related]
18. miRNA-195 sensitizes human hepatocellular carcinoma cells to 5-FU by targeting BCL-w.
Yang X; Yin J; Yu J; Xiang Q; Liu Y; Tang S; Liao D; Zhu B; Zu X; Tang H; Lei X
Oncol Rep; 2012 Jan; 27(1):250-7. PubMed ID: 21947305
[TBL] [Abstract][Full Text] [Related]
19. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z
Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863
[TBL] [Abstract][Full Text] [Related]
20. USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway.
Ling S; Li J; Shan Q; Dai H; Lu D; Wen X; Song P; Xie H; Zhou L; Liu J; Xu X; Zheng S
Mol Oncol; 2017 Jun; 11(6):682-695. PubMed ID: 28417539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
